Low-dose nivolumab with neoadjuvant chemotherapy and oral metronomic therapy in borderline resectable oral cavity squamous cell carcinoma: a phase II trial

Authors

Institutions

Publication Details

Journal
The Lancet Regional Health - Southeast Asia
Published
2026-03-05
DOI
https://doi.org/10.1016/j.lansea.2026.100743
Primary Topic
Head and Neck Cancer Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Low-dose nivolumab with neoadjuvant chemotherapy and oral metronomic therapy in borderline resectable oral cavity squamous cell carcinoma: a phase II trial

A. Subbarao, Praveen Kumar Marimuthu, Sharief K Sidhique, A. Joel et al.
The Lancet Regional Health - Southeast Asia
Head and Neck Cancer Studies
article

Low-dose nivolumab with neoadjuvant chemotherapy and oral metronomic therapy in borderline resectable oral cavity squamous cell carcinoma: a phase II trial

A. Subbarao, Praveen Kumar Marimuthu, Sharief K Sidhique, A. Joel, Kovilapu Harikrishna, Jansi Rani, Simon Pavamani, Divya Bala Thumaty, Rajesh Isiah, Manu Mathew, Jino Victor Wilson, Deepa Susan Joy Philip, Chitra Renukaradhya, J. Riju, A. O. John, A. Tirkey, M. Thomas, B. K. Sasidharan, S. Sahu, J. T. Georgy, Rajiv C. Michael, Konduru Vidya, Mansi Agrawal, Ashish Singh
article en

Abstract

No abstract available for this paper.
The Lancet Regional Health - Southeast AsiaVol. 47
Christian Medical College, Vellore (IN)
Christian Medical College, Vellore
Openalex Percentile: Top 30%
Head and Neck Cancer Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.